DaVita reports muted analyst consensus, shares hold above 210 dollars
23.06.2026 - 22:12:05 | ad-hoc-news.deBy Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 22:10.
DaVita Inc. (US23918K1088) sits in a cautious spotlight on the NYSE as fresh data show a muted analyst stance and a share price above prevailing targets. Wall Street research houses broadly rate the stock as a Hold according to the latest consensus snapshot.
What the consensus shows
Six analysts currently cover DaVita with a combined consensus rating of Hold, with 33 percent at Strong Buy, 50 percent at Hold and 17 percent at Sell, according to a recent aggregation of Wall Street views.Analyst consensus data on DaVita The average price target stands around 199 dollars per share, implying limited upside versus the present market level.Forecast overview including DaVita targets
DaVita shares on the NYSE
DaVita shares trade on the NYSE under the ticker DVA and most recently closed at approximately 211.6 dollars per share, based on end-of-day data for June 23, 2026.DaVita price history and latest close This level sits noticeably above the average analyst target near 199 dollars, highlighting the cautious tone of current research despite the solid price area.
All news and analysis on the DaVita shares
Further background, regulatory filings and price data on DaVita are available in the dedicated topic section and on the company’s Investor Relations page.
The business behind DaVita
DaVita earns most of its revenue from kidney care services, in particular outpatient dialysis treatments provided through a broad clinic network in the United States and selected international markets.Company overview describing DaVita’s kidney care focus The group also offers related education programs and ancillary services around chronic kidney disease management.
Where the DaVita shares trade today
The DaVita shares (US23918K1088) trade on 2026-06-23 at around 211.6 dollars on the NYSE, based on the latest available closing print and intraday indications for ticker DVA.
Key data on the DaVita shares
- Company: DaVita Inc.
- ISIN: US23918K1088
- WKN: A0DNRD
- Ticker: DVA
- Trading venue: NYSE
- Price (as of 2026-06-23, 22:10): 211.6 USD
- Market cap: approximately 18.5 billion USD (as of 2026-06-23)
- Sector / industry: Health Care Services / Dialysis
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This text is for information purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. Figures and assessments are based on sources cited and may change over time.
